Literature DB >> 6687321

Wilson's disease in one identical twin and treatment by triethylene tetramine 2HCl in another case.

R G Watson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687321      PMCID: PMC2448028     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


× No keyword cloud information.
  9 in total

1.  The distribution of copper in human brain.

Authors:  P J WARREN; C J EARL; R H THOMPSON
Journal:  Brain       Date:  1960-12       Impact factor: 13.501

2.  Copper metabolism.

Authors:  I H SCHEINBERG; I STERNLIEB
Journal:  Pharmacol Rev       Date:  1960-09       Impact factor: 25.468

3.  Wilson's disease; an inborn error of metabolism with multiple manifestations.

Authors:  A G BEARN
Journal:  Am J Med       Date:  1957-05       Impact factor: 4.965

4.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

5.  Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.

Authors:  J M Walshe
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

6.  Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.

Authors:  J M Walshe
Journal:  Q J Med       Date:  1973-07

7.  Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.

Authors:  R R Lindquist
Journal:  Arch Pathol       Date:  1969-04

8.  The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).

Authors:  J M Walshe
Journal:  Prog Clin Biol Res       Date:  1979

9.  Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.

Authors:  R H Haslam; A Sass-Kortsak; W Stout; M Berg
Journal:  Dev Pharmacol Ther       Date:  1980
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.